Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma

Volume: 6, Issue: 8, Pages: e23151 - e23151
Published: Aug 1, 2011
Abstract
Background Erythropoietin (Epo) administration has been reported to have tumor-promoting effects in anemic cancer patients. We investigated the prognostic impact of endogenous Epo in patients with pancreatic ductal adenocarcinoma (PDAC). Methodology The clinico-pathological relevance of hemoglobin (Hb, n = 150), serum Epo (sEpo, n = 87) and tissue expression of Epo/Epo receptor (EpoR, n = 104) was analyzed in patients with PDAC. Epo/EpoR...
Paper Details
Title
Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma
Published Date
Aug 1, 2011
Journal
Volume
6
Issue
8
Pages
e23151 - e23151
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.